These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment. Taibe NS; Kord MA; Badawy MA; Shytaj IL; Elhefnawi MM Ther Adv Respir Dis; 2022; 16():17534666221132736. PubMed ID: 36282077 [TBL] [Abstract][Full Text] [Related]
24. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments. Abdurrahman L; Fang X; Zhang Y Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374 [TBL] [Abstract][Full Text] [Related]
25. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants. Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303 [TBL] [Abstract][Full Text] [Related]
26. Pharmacological strategies to prevent SARS-CoV-2 infection and treat the early phases of COVID-19. Scarabel L; Guardascione M; Dal Bo M; Toffoli G Int J Infect Dis; 2021 Mar; 104():441-451. PubMed ID: 33476760 [TBL] [Abstract][Full Text] [Related]
27. Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2): A Review on Pathophysiology, Diagnosis, and Investigational Therapeuti. Sharma R; Khokhar D; Gupta B; Saxena P; Ghosh KK; Geda AK; Kuca K Curr Med Chem; 2021; 28(41):8559-8594. PubMed ID: 33949925 [TBL] [Abstract][Full Text] [Related]
28. Therapeutic Strategies in the Development of Anti-viral Drugs and Vaccines Against SARS-CoV-2 Infection. Bhatti JS; Bhatti GK; Khullar N; Reddy AP; Reddy PH Mol Neurobiol; 2020 Nov; 57(11):4856-4877. PubMed ID: 32808122 [TBL] [Abstract][Full Text] [Related]
29. Safety and Efficacy of Different Therapeutic Interventions on Prevention and Treatment of COVID-19. Gyanwali P; Sharma S; Pant S; Koirala P; Adhikari K; Koirala J; Dhimal M J Nepal Health Res Counc; 2020 Sep; 18(2):151-158. PubMed ID: 32969369 [TBL] [Abstract][Full Text] [Related]
30. Clinical progress of therapeutics and vaccines: Rising hope against COVID-19 treatment. Bandaru R; Rout SR; Kamble OS; Samal SK; Gorain B; Sahebkar A; Ahmed FJ; Kesharwani P; Dandela R Process Biochem; 2022 Jul; 118():154-170. PubMed ID: 35437418 [TBL] [Abstract][Full Text] [Related]
31. Host Protective Immunity against Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) and the COVID-19 Vaccine-Induced Immunity against SARS-CoV-2 and Its Variants. Noor R Viruses; 2022 Nov; 14(11):. PubMed ID: 36423150 [TBL] [Abstract][Full Text] [Related]
32. Clinical trials in the time of a pandemic. Ellenberg SS Clin Trials; 2020 Oct; 17(5):467-471. PubMed ID: 32650672 [TBL] [Abstract][Full Text] [Related]
33. Systematic Review of Clinical Insights into Novel Coronavirus (CoVID-19) Pandemic: Persisting Challenges in U.S. Rural Population. Lakhani HV; Pillai SS; Zehra M; Sharma I; Sodhi K Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32549334 [TBL] [Abstract][Full Text] [Related]
34. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. Wiersinga WJ; Rhodes A; Cheng AC; Peacock SJ; Prescott HC JAMA; 2020 Aug; 324(8):782-793. PubMed ID: 32648899 [TBL] [Abstract][Full Text] [Related]
35. Emergence, evolution, and vaccine production approaches of SARS-CoV-2 virus: Benefits of getting vaccinated and common questions. Hassanin AA; Haidar Abbas Raza S; Ahmed Ujjan J; Aysh ALrashidi A; Sitohy BM; Al-Surhanee AA; Saad AM; Mohamed Al-Hazani T; Osman Atallah O; Al Syaad KM; Ezzat Ahmed A; Swelum AA; El-Saadony MT; Sitohy MZ Saudi J Biol Sci; 2022 Apr; 29(4):1981-1997. PubMed ID: 34924802 [TBL] [Abstract][Full Text] [Related]
36. Coronavirus diseases and pregnancy: COVID-19,SARS, and MERS. Fathi M; Vakili K; Deravi N; Yaghoobpoor S; Ahsan E; Mokhtari M; Moshfeghi M; Vaezjalali M Przegl Epidemiol; 2020; 74(2):276-289. PubMed ID: 33112124 [TBL] [Abstract][Full Text] [Related]
37. TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351). Lee J; Lee J; Kim HJ; Ko M; Jee Y; Kim S Microbiol Spectr; 2021 Sep; 9(1):e0047221. PubMed ID: 34378968 [TBL] [Abstract][Full Text] [Related]